This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Bacteriophage Market

Market Insights on Bacteriophage covering sales outlook, demand forecast & up-to-date key trends

Bacteriophage Market By Product (Phage Probiotics, Phage Therapeutics), Route of Administration (Oral, Topical), Application (Gastroenterology, Respiratory Infections Treatment, Skin Infection Treatment, Wound Prophylaxis, Urogenital Infection Treatment) & Region - Forecast 2021 - 2031

Bacteriophage Market Outlook (2021-2031)

[266 Pages Report] The global demand for bacteriophage market is expected to witness significant growth at 4.2% CAGR from 2021 to 2031, topping a valuation of US$ 41.46 Mn in 2021. According to the study, the oral route of administration segment held a substantial share of around 97% in 2021 within the global market.

Market Outlook:

Data Points

Market Insights

Bacteriophage Market Value 2020

US$ 39.85 Mn

Bacteriophage Market Value 2021

US$ 41.46 Mn

Bacteriophage Market Value 2031

US$ 62.72 Mn

CAGR 2021-2031

4.2%

Bacteriophage Market Share of Top 5 Countries

55.8%

Bacteriophages are used as a dietary supplement as they are known to reduce the risk of incidence of food born infections by Escherichia, Salmonella and other gut pathogens. These dietary supplements contain a specific combination of bacteriophages which attacks particular organisms in the gut.

Phage therapeutics can be used for treatment and prevention of antibiotic resistance infections, urinary tract infections, dysentery and others. On account of these factors, the bacteriophage market is expected to grow at a significant rate over the forecast period. As per the study, bacteriophage market held nearly 1.2% of the global probiotic supplement market which was valued at US$ 34 Bn in 2021.

Customize this Report

Let us know your requirement to get
100% FREE customization

Bacteriophage Market Analysis From 2016 To 2020 Vs Outlook For 2021 To 2031

According to Future Market Insights, the overall bacteriophage sales were valued at around US$ 41.46 Mn in 2021. The market is projected to register 4.2% CAGR and top a valuation of US 67.72 Mn by the end of 2031.

Human gut is easily prone to attack by bacteriophages. As bacteriophages are bacteria eaters, they can easily affect gut microbiota population and in-turn influence gene expression patterns in microbes.

Hence, consumption of phage probiotics promotes growth of good bacteria over bad bacteria and maintain good balance and promotes healthy lifestyle among individuals. For instance, In June 2021, Life Extension launched new formula for supporting bowel regularity, FLORASSIST® Daily Bowel Regularity.

The formula contains clinically-studied Bifidobacterium lactis HN019, a probiotic strain shown to maintain bowel regularity and also defends against occasional constipation. A slew of such developments by key players is expected to boost the market.

Rising prevalence of antibiotic resistance and limited discoveries for new antibiotics is one of the major factor propelling the growth in the market. Phages are known as super bug, as they multiply at the site of action to support healthy immune function.

Bacteriophage Market Report Brochure

This has shifted the focus of healthcare professionals in developed countries towards research and development. This is projected to improve the demand in the bacteriophage market replacing the traditional probiotics.

For instance, in January 2020, Life Extension developed a novel approach for supporting healthy liver, FLORASSIST® Liver Restore™. This is a daily, synbiotic proprietary blend that combines clinically-studied PRO-biotic bacteria with PRE-biotic that helps those strains thrive in the gut.

By route of administration, oral route segment dominated the global market in 2021, contributing about 97% of the revenue share. The trend is likely to continue in future due to its ability to prevent plaque, decrease in inflammation of gums.

As per FMI, the global bacteriophage market is expected to be valued at US$ 67.72 Mn by the end of 2031 and is projected to register a CAGR of 4.2% in the forecast period.

What Are The Key Opportunities For Bacteriophage Manufacturers?

Growing emphasis on research and development of drugs and therapies for infectious diseases is expected to create immense growth opportunities in the market. Rising interest in development of drugs for applications such as infectious diseases and immunological disorders will further boost the market.

For instance, in June 2020, Microgen opened a Biological Research Centre for study of bacteriophages. The main purpose of this centre will be to improve treatment-and-prevention drugs being an alternative to antibiotics.

According to the World Health Organization, antibiotic-resistant infections could kill about 10 million people per year by 2050. There is a huge, unmet need in patients with bacterial infections, which are mostly very difficult to treat with traditional antibiotic therapy.

Furthermore, increasing antibiotic resistance pathogen needs to be treated with bacteriophage. Rising prevalence of antibiotic resistance has surged the demand for phage therapy. For instance, In October 2021, Intralytix, Inc. received clearance from the U.S. Food and Drug Administration (FDA) for an Investigational New Drug (IND) application for its product ShigActive™.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Are The Factors Restraining The Demand For Bacteriophage?

High cost of bacteriophage treatment is the major factor limiting the sales in the market. Due to the high cost of therapy, several healthcare facilities such as small hospitals & clinics in underdeveloped regions are not able to afford the treatment, restraining growth.

Low- to middle-income countries generate more revenue from antibiotics as compared to bacteriophage as they are cheaper and show immediate results. This is the major restraining factor for the market.

Country-Wise Insights

Why is the U.S. Considered to be the Most Lucrative Market for Bacteriophage?

“Rising Prevalence of Antibiotic Resistance to Fuel Bacteriophage Sales”

As per the study, the U.S. is expected to dominate North America bacteriophage market, accounting for a total market share of over 90% in 2021.

Growth in the market is driven by rising prevalence of antibiotic resistance and increasing demand for an alternative to antibiotics in the country.

How Big is the Opportunity for Bacteriophage Market in Russia?

“Fast Track Approval for Bacteriophage Formulations to Boost the Market

Russia is set to exhibit a CAGR of 5.8% in Europe bacteriophage market during the forecast period. Increase in research & development activities and technological advancements will promote the growth in the market.

Another factor driving the growth of this market in Russia is favourable regulatory policies and less stringent rules for approval of bacteriophage formulations as compared to USFDA.

Why is Demand for Bacteriophage Increasing in Australia?

“Australia to Emerge as the Most Lucrative Bacteriophage Market in Oceania”

Sales of bacteriophage in Australia are projected to increase at a CAGR rate of 5.2% during the forecast period. Growth of the bacteriophage market in the country is attributed to the rising wave of advancements in phage therapy strategies in the region of Oceania.

What is the Demand Outlook for Bacteriophage in India?

“India Bacteriophage Market to Spearhead the Growth in South Asia”

India accounted for about 29% of market share in 2021 and is projected to increase with a CAGR of 5.6% during the forecast period. Demand for bacteriophage is witnessing a rapid increase in antibacterial resistant infections in India.

Key companies in India are collaborating and extending their partnerships with pre-existing giants to expand their product portfolio. This is expected to facilitate the growth in the market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-Wise Insights

Which Product Type is the Most Preferred?

“Phage Probiotics to Account for More than 9 out of 10 Bacteriophage Sales”

In terms of product, the phage probiotics segment accounted for about 95.5% of market share in 2021 and is expected to register a CAGR of 4.2% in the forecast period. The growth of this product is associated with its ability of improving gut flora diversity and promoting growth of good bacteria.

Which Route of Administration will Hold Significant Share in Bacteriophage Market?

“Preference for Non-Invasive Treatment to Increase the Demand for Oral Route of Administration in Bacteriophage Market”

Oral route of administration benefits the most as they have more than 96% share in revenue and is expected to grow at a CAGR of 4.3% in the forecast period. This is the most preferred route of administration since it is self-administrable, non- invasive and cost effective as well.

Which is the Chief Application in Bacteriophage Market?

“Demand for Bacteriophage Formulations in Gastroenterology to Increase”

In terms of application, sales of bacteriophage in gastroenterology reached a valuation of US$ 37.35 Mn in 2021 and is expected to increase at a CAGR of 4.3% in the forecast period. Bacteriophages are used as dietary supplements to improve gut health. Bacteriophages are still not approved by USFDA as a treatment option for many antibiotic-resistant infections in many regions.

Which Distribution Channel is Highly Sought-After in Bacteriophage Market?

“Sales of Bacteriophage to Surge through Retail Pharmacies”

Based on distribution channel, retail pharmacies segment will register a CAGR of 3.7% in the forecast period. Retail pharmacies offer various advantages such as better access to generic as well as competitive drugs, lower unit costs and assure quality customer service.

Competitive Landscape

Leading bacteriophage manufacturers are focusing on geographical expansion to increase their revenue & expand their footprint in emerging countries by acquisition of local market players.

Strategic collaborations, acquisitions, expansion, product launches, agreements and research sponsorship are the key strategies adopted by manufacturers to increase the product sales in different geographies.

For instance,

  • In August 2021, Carillon Miami Wellness Resort partnered with the biostation to launch a new functional medicine practice located at the resort’s award-winning, 70,000-square-foot spa and wellness facility.
  • In November 2021 Intralytix and AB Agri partnered to explore the use of bacteriophages in animal feed as an alternative to antibiotics and other drugs.
  • In June 2021, BioChimpharm expanded its production capacity with the support of European union and FAO to develop an alternative to antibiotics.

Scope Of Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa

Key Countries Covered

US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Russia, Poland, Georgia China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, Turkey and South Africa

Key Market Segments Covered

Product, Route of administration, Application, Distribution channel and Region

Key Companies Profiled

  • Life extension
  • Arthur Andrew Medical
  • Deerland Probiotics & Enzymes Inc.
  • BioChimpharm
  • Micreos Human Health
  • Designs for Health
  • Accelerated Health Systems LLC
  • The biostation
  • Microgen
  • IntraLytix Inc.

Pricing

Available upon Request

Key Market Segments Covered In Bacteriophage Industry Research

By Product:

  • Phage Probiotics
  • Phage Therapeutics

By Route of Administration:

  • Oral
  • Topical
  • Other

By Application:

  • Gastroeneterology
  • Respiratory infections market
  • Skin infection treatment
  • Wound prophylaxis
  • Urogenital infection treatment
  • Others

By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global bacteriophage market valued US$ 41.46 Mn in 2021 and is set to expand 1.5X over the next ten years.

The bacteriophage market is expected to reach US$ 67.72 Mn by end of 2031 at a CAGR of 4.2%

Growth in the market is underpinned by rising demand for phage probiotics, better alternative for antibiotics, strategic investment by manufacturers for development of phage therapeutics.

Europe is expected to lead the market, accounting for a market share of about 42% by value in 2021 in the global bacteriophage market.

Growing inclination towards preventive healthcare in conjunction with the development of efficient combination phase therapies and expansion of product pipeline are some of the important opportunities for growth in this market.

The U.S., Poland, Russia, Australia and Georgia are the top five countries which are expected to drive demand in bacteriophage market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion & Exclusion

3. Key Market Trends

    3.1. Key Trends Impacting The Market

    3.2. Innovation / Development Trends

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Growth Outlook

        4.1.2. Global Healthcare Expenditure Outlook

        4.1.3. Regional Healthcare Market Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Rising focus on Research and Development

        4.2.2. Rising prevalence of antimicrobial-resistance infection

        4.2.3. Increasing Use of Antibiotics

        4.2.4. Wide Range of Indication of Bacteriophage

        4.2.5. Rising Use of Bacteriophage as Vaccine Vehicles

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. COVID19 Crisis Analysis

    5.1. Current COVID19 Statistics and Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 Economic analysis

    5.4. COVID19 and Impact Analysis

        5.4.1. By Product

        5.4.2. By Route of Administration

        5.4.3. By Application

        5.4.4. By Distribution Channel

        5.4.5. By Country

6. Key Success Factors

    6.1. Antibiotics vs. Bacteriophage Therapy

    6.2. Disease Epidemiology

    6.3. Regulatory Scenario

    6.4. Pipeline Analysis

    6.5. Key Strategies by Manufacturers

    6.6. PESTEL Analysis

    6.7. PORTAL Analysis

7. Global Bacteriophage Market Demand (in Value or Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Product 

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis by Product, 2016-2020

    8.3. Current and Future Market Size (US$ Mn) and Forecast by Product, 2021-2031

        8.3.1. Phage Probiotics

        8.3.2. Phage Therapeutics

    8.4. Market Attractiveness Analysis by Product 

9. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Route of Administration

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis by Usage, 2016-2020

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Route of Administration, 2021-2031

        9.3.1. Oral 

        9.3.2. Topical

        9.3.3. Others

    9.4. Market Attractiveness Analysis by Route of Administration

10. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Application 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis by Application, 2016-2020

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2021-2031

        10.3.1. Gastroenterology

        10.3.2. Respiratory infections treatment

        10.3.3. Skin infection treatment

        10.3.4. Wound prophylaxis 

        10.3.5. Urogenital infection treatment

        10.3.6. Others

    10.4. Market Attractiveness Analysis by Application

11. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Distribution Channel

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2016-2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Distribution Channel, 2021-2031

        11.3.1. Retail Pharmacies

        11.3.2. Hospital Pharmacies

        11.3.3. Online Pharmacies

    11.4. Market Attractiveness Analysis by Distribution Channel

12. Global Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis by Region, 2016-2020

    12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2021-2031

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. Middle East and Africa (MEA)

        12.3.5. South Asia

        12.3.6. East Asia

        12.3.7. Oceania

    12.4. Market Attractiveness Analysis by Region

13. North America Bacteriophage Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    13.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Product

        13.3.3. By Route of Administration

        13.3.4. By Application

        13.3.5. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Distribution Channel

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Latin America Bacteriophage Market 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    14.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031

        14.3.1. By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Product

        14.3.3. By Route of Administration

        14.3.4. By Application

        14.3.5. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Distribution Channel

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Europe Bacteriophage Market 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    15.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. Poland

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Product

        15.3.3. By Route of Administration

        15.3.4. By Application

        15.3.5. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By Route of Administration

        15.4.4. By Application

        15.4.5. By Distribution Channel

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. South Asia Bacteriophage Market 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    16.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Product

        16.3.3. By Route of Administration

        16.3.4. By Application

        16.3.5. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Distribution Channel

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. East Asia Bacteriophage Market 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    17.4. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031

        17.4.1. By Country

            17.4.1.1. China

            17.4.1.2. Japan

            17.4.1.3. South Korea

        17.4.2. By Product

        17.4.3. By Route of Administration

        17.4.4. By Application

        17.4.5. By Distribution Channel

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Distribution Channel

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

18. Oceania Bacteriophage Market 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    18.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product

        18.3.3. By Route of Administration

        18.3.4. By Application

        18.3.5. By Distribution Channel

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Distribution Channel

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Bacteriophage Market 2016-2020 and Forecast 2021-2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2016-2020

    19.3. Market Size (US$ Mn) Forecast by Market Taxonomy, 2021-2031

        19.3.1. By Country

            19.3.1.1. GCC Countries

            19.3.1.2. South Africa

            19.3.1.3. Turkey

            19.3.1.4. Rest of Middle East and Africa

        19.3.2. By Product

        19.3.3. By Route of Administration

        19.3.4. By Application

        19.3.5. By Distribution Channel

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Distribution Channel

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Country Level Bacteriophage Market Analysis 2021 & 2031 

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis

        20.1.2. Global VS. Country Growth Comparison

    20.2. U.S. Bacteriophage Market Analysis

        20.2.1. By Distribution Channel

    20.3. Canada Bacteriophage Market Analysis

        20.3.1. By Distribution Channel

    20.4. Mexico Bacteriophage Market Analysis

        20.4.1. By Distribution Channel

    20.5. Brazil Bacteriophage Market Analysis

        20.5.1. By Distribution Channel

    20.6. Argentina Bacteriophage Market Analysis

        20.6.1. By Distribution Channel 

    20.7. U.K Bacteriophage Market Analysis

        20.7.1. By Distribution Channel

    20.8. Germany Bacteriophage Market Analysis

        20.8.1. By Distribution Channel

    20.9. Italy Bacteriophage Market Analysis

        20.9.1. By Distribution Channel

    20.10. France Bacteriophage Market Analysis

        20.10.1. By Distribution Channel

    20.11. Poland Bacteriophage Market Analysis

        20.11.1. By Product

        20.11.2. By Route of Administration

        20.11.3. By Application

        20.11.4. By Distribution Channel

    20.12. Spain Bacteriophage Market Analysis

        20.12.1. By Distribution Channel

    20.13. Georgia Bacteriophage Market Analysis

        20.13.1. By Product

        20.13.2. By Route of Administration

        20.13.3. By Application

        20.13.4. By Distribution Channel

    20.14. Russia Bacteriophage Market Analysis

        20.14.1. By Product

        20.14.2. By Route of Administration

        20.14.3. By Application

        20.14.4. By Distribution Channel

    20.15. China Bacteriophage Market Analysis

        20.15.1. By Distribution Channel

    20.16. Japan Bacteriophage Market Analysis

        20.16.1. By Distribution Channel

    20.17. South Korea Bacteriophage Market Analysis

        20.17.1. By Distribution Channel

    20.18. India Bacteriophage Market Analysis

        20.18.1. By Distribution Channel

    20.19. Thailand Bacteriophage Market Analysis

        20.19.1. By Distribution Channel

    20.20. Malaysia Bacteriophage Market Analysis

        20.20.1. By Distribution Channel

    20.21. Indonesia Bacteriophage Market Analysis

        20.21.1. By Distribution Channel

    20.22. Australia Bacteriophage Market Analysis

        20.22.1. By Distribution Channel

    20.23. New Zealand Bacteriophage Market Analysis

        20.23.1. By Distribution Channel

    20.24. Turkey Bacteriophage Market Analysis

        20.24.1. By Distribution Channel

    20.25. GCC Countries Bacteriophage Market Analysis

        20.25.1. By Distribution Channel

    20.26. North Africa Bacteriophage Market Analysis

        20.26.1. By Distribution Channel

    20.27. South Africa Bacteriophage Market Analysis

        20.27.1. By Distribution Channel

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies 

    21.2. Market Share Analysis of Top Players

    21.3. Market Presence Analysis

        21.3.1. By Regional footprint of players

        21.3.2. Product footprint of players

        21.3.3. Channel footprint of players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive 

        22.3.1. Life Extension

            22.3.1.1. Overview & Key Financials

            22.3.1.2. Product Portfolio

            22.3.1.3. Sales Footprint

            22.3.1.4. SWOT Analysis

            22.3.1.5. Strategy

                22.3.1.5.1. Marketing Strategy

                22.3.1.5.2. Product Strategy

                22.3.1.5.3. Channel Strategy 

        22.3.2. Arthur Andrew Medical

            22.3.2.1. Overview & Key Financials

            22.3.2.2. Product Portfolio

            22.3.2.3. Sales Footprint

            22.3.2.4. SWOT Analysis

            22.3.2.5. Strategy

                22.3.2.5.1. Marketing Strategy

                22.3.2.5.2. Product Strategy

                22.3.2.5.3. Channel Strategy

        22.3.3. Deerland Probiotics & Enzymes Inc.

            22.3.3.1. Overview & Key Financials

            22.3.3.2. Product Portfolio

            22.3.3.3. Sales Footprint

            22.3.3.4. SWOT Analysis

            22.3.3.5. Strategy

                22.3.3.5.1. Marketing Strategy

                22.3.3.5.2. Product Strategy

                22.3.3.5.3. Channel Strategy

        22.3.4. BioChimpharm

            22.3.4.1. Overview & Key Financials

            22.3.4.2. Product Portfolio

            22.3.4.3. Sales Footprint

            22.3.4.4. SWOT Analysis

            22.3.4.5. Strategy

                22.3.4.5.1. Marketing Strategy

                22.3.4.5.2. Product Strategy

                22.3.4.5.3. Channel Strategy 

        22.3.5. Micreos Human Health

            22.3.5.1. Overview & Key Financials

            22.3.5.2. Product Portfolio

            22.3.5.3. Sales Footprint

            22.3.5.4. SWOT Analysis

            22.3.5.5. Strategy

                22.3.5.5.1. Marketing Strategy

                22.3.5.5.2. Product Strategy

                22.3.5.5.3. Channel Strategy 

        22.3.6. Designs for Health

            22.3.6.1. Overview & Key Financials

            22.3.6.2. Product Portfolio

            22.3.6.3. Sales Footprint

            22.3.6.4. SWOT Analysis

            22.3.6.5. Strategy

                22.3.6.5.1. Marketing Strategy

                22.3.6.5.2. Product Strategy

                22.3.6.5.3. Channel Strategy 

        22.3.7. Accelerated Health Systems llc

            22.3.7.1. Overview & Key Financials

            22.3.7.2. Product Portfolio

            22.3.7.3. Sales Footprint

            22.3.7.4. SWOT Analysis

            22.3.7.5. Strategy

                22.3.7.5.1. Marketing Strategy

                22.3.7.5.2. Product Strategy

                22.3.7.5.3. Channel Strategy 

        22.3.8. The biostation

            22.3.8.1. Overview & Key Financials

            22.3.8.2. Product Portfolio

            22.3.8.3. Sales Footprint

            22.3.8.4. SWOT Analysis

            22.3.8.5. Strategy

                22.3.8.5.1. Marketing Strategy

                22.3.8.5.2. Product Strategy

                22.3.8.5.3. Channel Strategy 

        22.3.9. Probiotic America

            22.3.9.1. Overview & Key Financials

            22.3.9.2. Product Portfolio

            22.3.9.3. Sales Footprint

            22.3.9.4. SWOT Analysis

            22.3.9.5. Strategy

                22.3.9.5.1. Marketing Strategy

                22.3.9.5.2. Product Strategy

                22.3.9.5.3. Channel Strategy 

        22.3.10. Microgen

            22.3.10.1. Overview & Key Financials

            22.3.10.2. Product Portfolio

            22.3.10.3. Sales Footprint

            22.3.10.4. SWOT Analysis

            22.3.10.5. Strategy

                22.3.10.5.1. Marketing Strategy

                22.3.10.5.2. Product Strategy

                22.3.10.5.3. Channel Strategy 

        22.3.11. IntraLytix Inc.

            22.3.11.1. Overview & Key Financials

            22.3.11.2. Product Portfolio

            22.3.11.3. Sales Footprint

            22.3.11.4. SWOT Analysis

            22.3.11.5. Strategy

                22.3.11.5.1. Marketing Strategy

                22.3.11.5.2. Product Strategy

                22.3.11.5.3. Channel Strategy 

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 02: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 03: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 04: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 05: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 06: North America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 07: North America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 08: North America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 09: North America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 10: North America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 11: Latin America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 12: Latin America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 13: Latin America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 14: Latin America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 15: Latin America Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 16: Europe Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 17: Europe Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 18: Europe Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 19: Europe Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 20: Europe Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 21: South Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 22: South Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 23: South Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 24: South Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 25: South Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 26: East Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 27: East Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 28: East Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 29: East Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 30: East Asia Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 31: Oceania Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 32: Oceania Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 33: Oceania Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 34: Oceania Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 35: Oceania Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 36: MEA Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 37: MEA Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Table 38: MEA Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Table 39: MEA Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Table 40: MEA Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Global Bacteriophage Market Historical Market Value, 2016-2020

Figure 02: Global Bacteriophage Market Value (US$ Mn) & Y-o-Y Growth (%),

Figure 03:- Global Bacteriophage Market Absolute $ Opportunity, 2021 –2031

Figure 04: Global Bacteriophage Market Analysis by Product –2021 & 2031

Figure 05: Global Bacteriophage Market Y-o-Y Growth Projections by Product, 2021 – 2031

Figure 06: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Figure 07: Global Bacteriophage Market Analysis by Route of Administration –2021 & 2031

Figure 08: Global Bacteriophage Market Y-o-Y Growth Projections by Route of Administration, 2021 – 2031

Figure 09: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration

Figure 10: Global Bacteriophage Market Analysis by Application–2021 & 2031

Figure 11: Global Bacteriophage Market Y-o-Y Growth Projections by Application, 2021 – 2031

Figure 12: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Application

Figure 13: Global Bacteriophage Market Analysis by Distribution Channel –2021 & 2031

Figure 14: Global Bacteriophage Market Y-o-Y Growth Projections by Distribution Channel, 2021 – 2031

Figure 15: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

Figure 16: Global Bacteriophage Market Analysis by Region –2021 & 2031

Figure 17: Global Bacteriophage Market Y-o-Y Growth Projections by Region, 2021 – 2031

Figure 18: Global Bacteriophage Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Figure 19: North America Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)

Figure 20: North America Bacteriophage Market Value Share, By Country, 2021 (E)

Figure 21: North America Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020

Figure 22: North America Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031

Figure 23: North America Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031

Figure 24: North America Bacteriophage Market Attractiveness Analysis by Country, 2021–2031

Figure 25: Latin America Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)

Figure 26: Latin America Bacteriophage Market Value Share, By Country, 2021 (E)

Figure 27: Latin America Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020

Figure 28: Latin America Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031

Figure 29: Latin America Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031

Figure 30: Latin America Bacteriophage Market Attractiveness Analysis by Country, 2021–2031

Figure 31: Europe Bacteriophage Market Value Share, By Product, 2021 (E)

Figure 32: Europe Bacteriophage Market Value Share, By Applications, 2021 (E)

Figure 33: Europe Bacteriophage Market Value Share, By Route of Administration, 2021 (E)

Figure 34: Europe Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)

Figure 35: Europe Bacteriophage Market Value Share, By Country, 2021 (E)

Figure 36: Europe Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020

Figure 37: Europe Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031

Figure 38: Europe Bacteriophage Market Attractiveness Analysis by Product, 2021–2031

Figure 39: Europe Bacteriophage Market Attractiveness Analysis by Route of Administration, 2021–2031

Figure 40: Europe Bacteriophage Market Attractiveness Analysis by Application, 2021–2031

Figure 41: Europe Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031

Figure 42: Europe Bacteriophage Market Attractiveness Analysis by Country, 2021–2031

Figure 43: South Asia Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)

Figure 44: South Asia Bacteriophage Market Value Share, By Country, 2021 (E)

Figure 45: South Asia Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020

Figure 46: South Asia Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031

Figure 47: South Asia Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031

Figure 48: South Asia Bacteriophage Market Attractiveness Analysis by Country, 2021–2031

Figure 49: East Asia Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)

Figure 50: East Asia Bacteriophage Market Value Share, By Country, 2021 (E)

Figure 51: East Asia Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020

Figure 52: East Asia Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031

Figure 53: East Asia Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031

Figure 54: East Asia Bacteriophage Market Attractiveness Analysis by Country, 2021–2031

Figure 55: Oceania Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)

Figure 56: Oceania Bacteriophage Market Value Share, By Country, 2021 (E)

Figure 57: Oceania Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020

Figure 58: Oceania Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031

Figure 59: Oceania Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031

Figure 60: Oceania Bacteriophage Market Attractiveness Analysis by Country, 2021–2031

Figure 61: MEA Bacteriophage Market Value Share, By Distribution Channel, 2021 (E)

Figure 62: MEA Bacteriophage Market Value Share, By Country, 2021 (E)

Figure 63: MEA Bacteriophage Market Size (US$ Mn) Analysis, 2016-2020

Figure 64: MEA Bacteriophage Market Size (US$ Mn) & Y-o-Y Growth (%), 2021–2031

Figure 65: MEA Bacteriophage Market Attractiveness Analysis by Distribution Channel, 2021–2031

Figure 66: MEA Bacteriophage Market Attractiveness Analysis by Country, 2021–2031

Figure 67: U.S. Market Value Proportion Analysis

Figure 68: U.S. Market Value Proportion Analysis

Figure 69: U.S. Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 70: Canada Market Value Proportion Analysis

Figure 71: Canada Market Value Proportion Analysis

Figure 72: Canada Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 73: Brazil Market Value Proportion Analysis

Figure 74: Brazil Market Value Proportion Analysis

Figure 75: Brazil Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 76: Mexico Market Value Proportion Analysis

Figure 77: Mexico Market Value Proportion Analysis

Figure 78: Mexico Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 79: Argentina Market Value Proportion Analysis

Figure 80: Argentina Market Value Proportion Analysis

Figure 81: Argentina Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 82: U.K Market Value Proportion Analysis

Figure 83: U.K Market Value Proportion Analysis

Figure 84: U.K Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 85: Germany Market Value Proportion Analysis

Figure 86: Germany Market Value Proportion Analysis

Figure 87: Germany Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 88: Italy Market Value Proportion Analysis

Figure 89: Italy Market Value Proportion Analysis

Figure 90: Italy Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 91: France Market Value Proportion Analysis

Figure 92: France Market Value Proportion Analysis

Figure 93: France Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 94: Poland Market Value Proportion Analysis

Figure 95: Poland Market Value Proportion Analysis

Figure 96: Poland Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 97: Poland Bacteriophage Market Share Analysis (%), By Product, 2021 & 2031

Figure 98: Poland Bacteriophage Market Share Analysis (%), By Route of Administration, 2021 & 2031

Figure 99: Poland Bacteriophage Market Share Analysis (%), By Applications, 2021 & 2031

Figure 100: Spain Market Value Proportion Analysis

Figure 101: Spain Market Value Proportion Analysis

Figure 102: Spain Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 103: Georgia Market Value Proportion Analysis

Figure 104: Georgia Market Value Proportion Analysis

Figure 105: Georgia Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 106: Georgia Bacteriophage Market Share Analysis (%), By Product, 2021 & 2031

Figure 107: Georgia Bacteriophage Market Share Analysis (%), By Route of Administration, 2021 & 2031

Figure 108: Georgia Bacteriophage Market Share Analysis (%), By Applications, 2021 & 2031

Figure 109: Russia Market Value Proportion Analysis

Figure 110: Russia Market Value Proportion Analysis

Figure 111: Russia Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 112: Russia Bacteriophage Market Share Analysis (%), By Product, 2021 & 2031

Figure 113: Russia Bacteriophage Market Share Analysis (%), By Route of Administration, 2021 & 2031

Figure 114: Russia Bacteriophage Market Share Analysis (%), By Applications, 2021 & 2031

Figure 115: China Market Value Proportion Analysis

Figure 116: China Market Value Proportion Analysis

Figure 117: China Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 118: Japan Market Value Proportion Analysis

Figure 119: Japan Market Value Proportion Analysis

Figure 120: Japan Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 121: South Korea Market Value Proportion Analysis

Figure 122: South Korea Market Value Proportion Analysis

Figure 123: South Korea Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 124: India Market Value Proportion Analysis

Figure 125: India Market Value Proportion Analysis

Figure 126: India Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 127: Thailand Market Value Proportion Analysis

Figure 128: Thailand Market Value Proportion Analysis

Figure 129: Thailand Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 130: Malaysia Market Value Proportion Analysis

Figure 131: Malaysia Market Value Proportion Analysis

Figure 132: Malaysia Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 133: Indonesia Market Value Proportion Analysis

Figure 134: Indonesia Market Value Proportion Analysis

Figure 135: Indonesia Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 136: Australia Market Value Proportion Analysis

Figure 137: Australia Market Value Proportion Analysis

Figure 138: Australia Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 139: New Zealand Market Value Proportion Analysis

Figure 140: New Zealand Market Value Proportion Analysis

Figure 141: New Zealand Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 142: Turkey Market Value Proportion Analysis

Figure 143: Turkey Market Value Proportion Analysis

Figure 144: Turkey Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 145: GCC Countries Market Value Proportion Analysis

Figure 146: GCC Countries Market Value Proportion Analysis

Figure 147: GCC Countries Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 148: North Africa Market Value Proportion Analysis

Figure 149: North Africa Market Value Proportion Analysis

Figure 150: North Africa Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Figure 151: South Africa Market Value Proportion Analysis

Figure 152: South Africa Market Value Proportion Analysis

Figure 153: South Africa Bacteriophage Market Share Analysis (%) By Distribution Channel, 2021 & 2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate